Denali Therapeutics Inc. (DNLI)
Market Closed
10 Sep, 20:00
$
21. 40
-0.17
-0.7881%
Pre Market
$
+1.11 +5.1869% 22. 51
3.54B Market Cap
- P/E Ratio
- Div Yield
938,544 Volume
-1.08 Eps
$ 21.57
Previous Close 
Want to track DNLI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Denali Therapeutics Inc. (DNLI) Statistics
Valuation metrics
Market Cap 3.54B
Enterprise value 3.36B
Trailing P/E (ttm) -7.85
Forward P/E -7.78
PEG ratio 4.58
Price/Sales (ttm) 981.15
Price/Book (mrq) 5
Enterprise Value/Revenue 932.86
Enterprise Value/EBITDA -6.76
Overview
Shares outstanding 156.18M
Float 144.36M
Shares short 15.42M
% Held by insiders 0.09%
% Held by institutions 0.98%
Average volume (10 days) 1.22M
Average volume (90 days) 1.73M
Price summary
52-Week low 12.58
52-Week high 27.3
Beta 1.1
50-Day moving average 23.47
200-Day moving average 20.9
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -141.91%
Operating margin -150.58%
Operational effectiveness
Return on assets -0.44%
Return on equity -0.55%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.02
Quarterly revenue growth (yoy) -
Gross profit (ttm) -418.78M
EBITDA -540.53M
Net income to common (ttm) -512.54M
Diluted EPS (ttm) -2.73
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 867.88M
Total cash per share (mrq) 3.79
Total debt (mrq) 42.29M
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 8.37%
Book value per share (mrq) 4.46
Cash Flow
Cash flow statement -412.6M
Levered free cash flow (LFCF) -244.19M
